-+ 0.00%
-+ 0.00%
-+ 0.00%

NAUTILUS BIOTECHNOLOGY, INC. : LEERINK PARTNERS INITIATES COVERAGE WITH OUTPERFORM RATING; PRICE TARGET $4

Reuters·09/09/2026 10:20:24

Please log in to view news